Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
- First approval
- Canada, 2001 · United States, 1992 · European Union, 2021
- Also known as
- Bordetella pertussis filamentous hemagglutinin vaccine, inactivated · Filamentous haemagglutinin · Filamentous haemagglutinin adsorbed
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which companies are running trials of Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account